BridgeBio Pharma prices oversubscribed secondary share offering
BridgeBio Pharma (BBIO) announces pricing of an oversubscribed secondary offering aimed at diversifying its institutional shareholder base.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.